Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report.

Lapins J, Radros N, Schultz K, Vassilaki I, Linder Stragliotto C, Helgadottir H.

Open source

DOI: 10.2340/1651-226x.2026.44993
Published: 2026-02-03
Container: Acta Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2340/1651-226x.2026.44993,
  title = {Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report.},
  author = {Lapins J and  Radros N and  Schultz K and  Vassilaki I and  Linder Stragliotto C and  Helgadottir H.},
  year = {2026},
  journal = {Acta Oncol},
  doi = {10.2340/1651-226x.2026.44993},
  url = {https://doi.org/10.2340/1651-226x.2026.44993}
}

RIS

TY  - JOUR
TI  - Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report.
AU  - Lapins J
AU  -  Radros N
AU  -  Schultz K
AU  -  Vassilaki I
AU  -  Linder Stragliotto C
AU  -  Helgadottir H.
PY  - 2026
JO  - Acta Oncol
DO  - 10.2340/1651-226x.2026.44993
UR  - https://doi.org/10.2340/1651-226x.2026.44993
ER  -

APA

J, L., N, R., K, S., I, V., C, L. S., & H., H. (2026). Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report.. Acta Oncol. https://doi.org/10.2340/1651-226x.2026.44993

Source records

europe-pmc · retrieved 2026-09-26T10:13:40.251Z
doaj · retrieved 2026-09-26T10:13:40.229Z